[HTML][HTML] N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming

K Zhang, T Zhang, Y Yang, W Tu, H Huang, Y Wang… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Chemoresistance to 5-fluorouracil (5-FU) is a major barrier to influence the
treatment efficiency of colorectal cancer (CRC) patients, while the precise molecular …

[HTML][HTML] The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling

Y Zhao, Y Chen, M Jin, J Wang - Theranostics, 2021 - ncbi.nlm.nih.gov
Epigenetic regulation involves a range of sophisticated processes which contribute to
heritable alterations in gene expression without altering DNA sequence. Regulatory events …

[HTML][HTML] The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer

CY Sun, D Cao, BB Du, CW Chen… - International Journal of …, 2022 - ncbi.nlm.nih.gov
RNA can be modified by over 170 types of distinct chemical modifications, and the most
abundant internal modification of mRNA in eukaryotes is N6-methyladenosine (m 6 A). The …

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion

X Cao, Q Geng, D Fan, Q Wang, X Wang, M Zhang… - Molecular cancer, 2023 - Springer
Abstract N6-methyladenosine (m6A) methylation is the most universal internal modification
in eukaryotic mRNA. With elaborate functions executed by m6A writers, erasers, and …

Crosstalk between RNA m6A modification and non-coding RNA contributes to cancer growth and progression

F Dai, Y Wu, Y Lu, C An, X Zheng, L Dai, Y Guo… - … Therapy-Nucleic Acids, 2020 - cell.com
N6-methyladenosine (m 6 A) is the most common RNA modification and has an important
role in normal development and tumorigenesis. The abnormal expression of m 6 A …

IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism

J Cui, J Tian, W Wang, T He, X Li, C Gu… - Cancer …, 2021 - Wiley Online Library
To explore the effect of insulin‐like growth factor 2 mRNA‐binding protein 2 (IGF2BP2) on
colorectal cancer (CRC) by recognizing the m6A modification of YAP mRNA thus activating …

MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1

QN Wu, XJ Luo, J Liu, YX Lu, Y Wang, J Qi, ZX Liu… - Cancer research, 2021 - AACR
Long noncoding RNAs (lncRNA) are involved in tumorigenesis and drug resistance.
However, the roles and underlying mechanisms of lncRNAs in colorectal cancer are still …

First small-molecule inhibitors targeting the RNA-binding protein IGF2BP2/IMP2 for cancer therapy

C Dahlem, A Abuhaliema, SM Kessler… - ACS chemical …, 2022 - ACS Publications
The RNA-binding protein IGF2BP2/IMP2/VICKZ2/p62 is overexpressed in several tumor
entities, promotes tumorigenesis and tumor progression, and has been suggested to worsen …

The diverse functions of IMP2/IGF2BP2 in metabolism

N Dai - Trends in Endocrinology & Metabolism, 2020 - cell.com
The human insulin-like growth factor 2 (IGF2) mRNA binding protein family (IMPs/IGF2BPs)
is involved in a spectrum of biological processes, including development, tumorigenesis …

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

X Hou, C Du, L Lu, S Yuan, M Zhan, P You… - World Journal of Surgical …, 2022 - Springer
Background As reported, preclinical animal models differ greatly from the human body. The
evaluation model may be the colossal obstacle for scientific research and anticancer drug …